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Strongyloidiasis is a parasitic infection that occurs in tropical regions. Hyperinfection, which is an accelerated
autoinfection, is often associated with an immunosuppressive state, such as HTLV-1 infection or steroid use.
Immunosuppression can also lead to reactivation of tuberculosis infection. These infections may have interacted as
a result of impaired cellular immunity. A 28-year-old Nepali male was referred to our hospital for slight abdominal
pain and high fever. An abdominal CT scan showed ascites and intestinal swelling. He was admitted with suspected
gastroenteritis. Results of stool microscopy on the third day of hospitalization revealed abundant strongylid larvae.
We diagnosed a Strongyloides hyperinfection and prescribed ivermectin. Although the numbers of strongylid
organisms in the patient’s stool soon diminished, his temperature remained high. After receiving a second dose of
ivermectin on day 17, he was transferred to a nearby hospital for observation, where he was noted to have massive
pleural effusion. He returned to our hospital where his pleural effusion was found to be positive for adenosine
deaminase (ADA), and he was diagnosed with a tuberculosis infection. Strongyloides hyperinfection can occur in a
non-endemic region. It can be associated with tuberculosis infection possibly due to impaired cellular immunity.
It is important to consider other possible infections when treating a patient with an infection associated with
impaired cellular immunity.
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Strongyloidiasis is a parasitic infection rarely seen in main-
land Japan. Hyperinfection of this organism sometimes
leads to fatal outcome because hyperinfections often occur
in patients whose cellular immunity is impaired. Here, we
present a case involving a 28-year-old Nepali male suffering
from a hyperinfection of Strongyloides whom we success-
fully treated with ivermectin. After the strongyloidiasis was
treated, the patient was found to have tuberculosis. This
case may suggest a relationship between strongyloidiasis
and tuberculosis attributable to impaired cellular immunity.
Case presentation
A 28-year-old Nepali male was referred to our hospital
with suspected gastroenteritis. He had a 3-week history of
high fever (around 38°C-39°C), appetite loss, and general* Correspondence: iwaci1ta@clin.medic.mie-u.ac.jp
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reproduction in any medium, provided the orfatigue. He had visited a nearby hospital, where he was
found, on abdominal CT, to have ascites and duodenal
swelling without free air. On admission to our hospital, he
complained of general fatigue and slight abdominal pain
but was not experiencing diarrhea. He had been in Japan
for 4 years and had not been back to Nepal for the last 2
years. He was living with four other Nepali males who
were not experiencing similar physical problems. He de-
nied being males who sex with males. He was a Hindu
and ate Japanese food bought in a nearby supermarket. He
had no remarkable past medical history and was not tak-
ing any medications. He works so hard on a supermarket
in Japan and he could not sleep well. He also feels loss of
appetite. He had been repeated low-grade fever around
37°C and general fatigue before coming to our hospital.
In general, the patient did not look sick. His height
was 170 cm, weight was 46.5 kg, and BMI was 16.1. His
blood pressure was 90/64, pulse rate 109/min, and body
temperature 36.2°C. His eyes were not anemic or icteric,
and chest sounds were clear. His abdomen was soft andLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lower quadrant.
Laboratory data on admission showed a slightly elevated
white blood cell count of 7,600/μl (neutrophil 5,920/μl,
lymphocyte 880/μl, monocyte 790/μl, eosinophil 0/μl, and
basophil 10/μl) and highly elevated CRP (13.9 mg/dl). His
albumin was low at 3.0 g/dl. A chest radiograph was clear,
and there were no signs of pneumonia. An abdominal
computed tomography (CT) scan on admission showed
ascites with swollen intestines but no free air (Figure 1).
We hospitalized the patient for observation. His tem-
perature rose to 40°C, and laboratory data on day 2
showed highly elevated inflammatory markers. Microbio-
logical studies including sputum, urine, and blood cultures
were all negative. He was constipated until day 3. His stool
on day 3 looked normal; it was not watery and contained
no blood. Stool microscopy revealed numerous strongylid
larvae (Figure 2). We diagnosed a Strongyloides hyper-
infection. Serum human T-cell leukemia virus type 1
(HTLV-1) and human immunodeficiency virus (HIV) tests
were negative, and CD4 counts were not decreased. We
prescribed 12 mg of ivermectin. Although his general con-
dition improved within 24 h after treatment in that he was
eating well and had no diarrhea or abdominal pain, his
temperature continued to exceed 39°C. The course of his
inflammatory laboratory data and temperature are shown
in Figure 3. On day 7, his stool sample was negative for
strongylid larvae. An abdominal CT scan on day 6 re-
vealed massive ascites, but the culture of the ascites on
day 9 was negative for strongylid larvae. He did not com-
plain of dyspnea throughout his hospitalization. A second
12-mg dose of ivermectin was administered on day 17.
After the second dose of ivermectin, the patient still had
a low-grade fever of 37°C-38°C. His laboratory data were
within the normal limit except for relatively low albuminFigure 1 Abdominal CT scan on admission. Ascites and intestinal swellin(2.6 g/dl) and still low lymphocyte count (470/μl). He looks
lethargy. We thought this is due to long-term hospital-
ization; thus, we transferred him to another hospital for fur-
ther rehabilitation. However, he returned to our hospital 4
days later for pleural effusion of unknown etiology. He had
massive pleural effusion in his left chest, and his ascites had
not diminished. Thoracentesis was performed on admis-
sion, and the pleural fluid was positive for adenosine deami-
nase (ADA) as 128 IU/l. Ascites were also positive for ADS
as 156.6 IU/l. QuantiFERON was positive, and mycobacter-
ial culture of gastric secretions revealed Mycobacterium tu-
berculosis. Sputum culture and Gaffky staining were
negative. Repeated stool microscopy was negative for
Strongyloides. The patient transferred to another hospital
for tuberculosis treatment.
We encountered a case of Strongyloides hyperinfection,
which is rarely seen in Japan. This patient also developed
a tuberculosis infection after successful treatment of his
strongyloidiasis. Although the relationship between these
two infections is not apparent, there may be an association
because of the unique characteristics of these infections.
Strongyloidiasis is endemic in tropical and subtropical
regions. In Japan, the Okinawa prefecture, which is in
the southern islands, is the only endemic region [1]. Be-
cause our patient had never been to the Okinawa prefec-
ture, we believe he became infected in Nepal. Strongyloides
can cause acute, chronic, hyper, and disseminated infec-
tion. Strongyloides hyperinfection occurs due to the unique
life cycle of the Strongyloides stercoralis. Their eggs are
embedded in the intestinal mucosal epithelium, and non-
infectious rhabditiform larvae hatch into the intestinal
lumen. The rhabditiform larvae become free-living adults
when secreted in feces into the soil. They can develop to
infectious filariform larvae, at which point they can pene-
trate human skin and invade the intestine via theg can be seen.
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Figure 2 Stool microscopy. Massive strongylids can be seen in the stool sample.
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ated autoinfection in which increasing numbers of infec-
tious filariform larvae are produced. Such hyperinfections
can occur when the host becomes immunosuppressed,
such as with steroid use or HTLV-1 infection [2]. These
infections can occur even 57 years after chronic infection
[3]. In chronic infection, more than 50% of patients are
asymptomatic [4]. Our patient had no symptoms and had


















Figure 3 Hematology and clinical chemistry data. Although the patient
his temperature remained high.believe this patient had been chronically infected since
he was in Nepal and became hyperinfected in Japan. Al-
though this patient does not have history of steroid use
or HTLV-1 infection. The patient had worked so hard
that he could not eat well. Malnutrition induced de-
creased number of lymphocyte and subsequently
hyperinfected with Strongyloides.
Tuberculosis is a re-emerging infection in Japan and is
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’s markers of inflammation decreased after ivermectin administration,
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There is one previous report in the literature of a co-
infection with strongyloidiasis and tuberculosis [5]. The au-
thors concluded that their patient developed tuberculosis
because of Strongyloides hyperinfection. However, the pos-
sibility that the patient developed strongyloidiasis hyper-
infection during the course of the tuberculosis infection is
not discussed. Similarly, in our patient, it is not clear
whether the strongyloidiasis stimulated the tuberculosis re-
activation or vice versa. However, it is clear that both
Strongyloides infection and tuberculosis infection are asso-
ciated with impaired cellular immunity [6].
Our patient’s lymphocyte count was low, indicating that
he was at risk of infection with both strongyloidiasis and tu-
berculosis. We estimated that malnutrition due to poor diet
caused decreased lymphocyte. The decreased lymphocyte
caused Strongyloides hyperinfection and tuberculosis. We
believe Strongyloides hyperinfection occurred earlier and
subsequently tuberculosis, because there were no signs and
symptoms of tuberculosis infection on admission. Regard-
less, patients with either strongyloidiasis or tuberculosis
should be examined carefully for other infections, particu-
larly when the patient has impaired cellular immunity.Conclusion
We encountered a unique case in Japan of Strongyloides
infection in a patient who subsequently was diagnosed
with tuberculosis. These infections can therefore present
even in non-endemic regions. It is important to consider
additional infections when treating a patient with an in-
fection caused by impairment of cellular immunity.Consent
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